These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20808846)

  • 1. Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.
    Wang J; Gigliotti F; Bhagwat SP; George TC; Wright TW
    PLoS Pathog; 2010 Aug; 6(8):e1001058. PubMed ID: 20808846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination Immunotherapy with Passive Antibody and Sulfasalazine Accelerates Fungal Clearance and Promotes the Resolution of
    Hoy Z; Wright TW; Elliott M; Malone J; Bhagwat S; Wang J; Gigliotti F
    Infect Immun; 2020 Jan; 88(2):. PubMed ID: 31611280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neither classical nor alternative macrophage activation is required for Pneumocystis clearance during immune reconstitution inflammatory syndrome.
    Zhang ZQ; Wang J; Hoy Z; Keegan A; Bhagwat S; Gigliotti F; Wright TW
    Infect Immun; 2015 Dec; 83(12):4594-603. PubMed ID: 26371121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Dual Benefit of Sulfasalazine on Pneumocystis Pneumonia-Related Immunopathogenesis and Antifungal Host Defense Does Not Require IL-4Rα-Dependent Macrophage Polarization.
    Zhang ZQ; Gigliotti F; Wright TW
    Infect Immun; 2023 Apr; 91(4):e0049022. PubMed ID: 36916933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-γ Limits Immunopathogenesis but Delays Fungal Clearance during Pneumocystis Pneumonia.
    Wang J; Zhang ZQ; Gigliotti F; Wright TW
    J Immunol; 2023 Nov; 211(9):1397-1405. PubMed ID: 37721419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation.
    Atochina-Vasserman EN; Gow AJ; Abramova H; Guo CJ; Tomer Y; Preston AM; Beck JM; Beers MF
    J Immunol; 2009 Feb; 182(4):2277-87. PubMed ID: 19201882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous heat-killed Escherichia coli improves alveolar macrophage activity and reduces Pneumocystis carinii lung burden in infant mice.
    Empey KM; Hollifield M; Garvy BA
    Infect Immun; 2007 Jul; 75(7):3382-93. PubMed ID: 17485459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with pneumocystis pneumonia.
    Lasbury ME; Durant PJ; Ray CA; Tschang D; Schwendener R; Lee CH
    J Immunol; 2006 Jun; 176(11):6443-53. PubMed ID: 16709801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic Programming of Alveolar Macrophages for Protective Antifungal Innate Immunity Against
    Bhagwat SP; Gigliotti F; Wang J; Wang Z; Notter RH; Murphy PS; Rivera-Escalera F; Malone J; Jordan MB; Elliott MR; Wright TW
    Front Immunol; 2018; 9():2131. PubMed ID: 30283457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1 Deficiency Promotes Macrophage Activation and T-Helper Cell Type 1/T-Helper Cell Type 17 Response in
    Zhang C; Rong HM; Li T; Zhai K; Tong ZH
    Am J Respir Cell Mol Biol; 2020 Jun; 62(6):767-782. PubMed ID: 32048861
    [No Abstract]   [Full Text] [Related]  

  • 11. Scavenger receptor A dampens induction of inflammation in response to the fungal pathogen Pneumocystis carinii.
    Hollifield M; Bou Ghanem E; de Villiers WJ; Garvy BA
    Infect Immun; 2007 Aug; 75(8):3999-4005. PubMed ID: 17548480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumocystis carinii enhances soluble mannose receptor production by macrophages.
    Fraser IP; Takahashi K; Koziel H; Fardin B; Harmsen A; Ezekowitz RA
    Microbes Infect; 2000 Sep; 2(11):1305-10. PubMed ID: 11018446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective ablation of lung epithelial IKK2 impairs pulmonary Th17 responses and delays the clearance of Pneumocystis.
    Perez-Nazario N; Rangel-Moreno J; O'Reilly MA; Pasparakis M; Gigliotti F; Wright TW
    J Immunol; 2013 Nov; 191(9):4720-30. PubMed ID: 24078701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina.
    Nelson MP; Christmann BS; Werner JL; Metz AE; Trevor JL; Lowell CA; Steele C
    J Immunol; 2011 Feb; 186(4):2372-81. PubMed ID: 21220696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation.
    Empey KM; Hollifield M; Schuer K; Gigliotti F; Garvy BA
    Infect Immun; 2004 Nov; 72(11):6211-20. PubMed ID: 15501746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical role for CARD9 in pneumocystis pneumonia host defence.
    Kottom TJ; Nandakumar V; Hebrink DM; Carmona EM; Limper AH
    Cell Microbiol; 2020 Oct; 22(10):e13235. PubMed ID: 32548948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia.
    Wright TW; Gigliotti F; Finkelstein JN; McBride JT; An CL; Harmsen AG
    J Clin Invest; 1999 Nov; 104(9):1307-17. PubMed ID: 10545529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced defense against Pneumocystis carinii mediated by a novel dectin-1 receptor Fc fusion protein.
    Rapaka RR; Goetzman ES; Zheng M; Vockley J; McKinley L; Kolls JK; Steele C
    J Immunol; 2007 Mar; 178(6):3702-12. PubMed ID: 17339468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host defenses against Pneumocystis carinii in mice selectively depleted of CD4+ lymphocytes.
    Beck JM; Warnock ML; Kaltreider HB; Shellito JE
    Chest; 1993 Feb; 103(2 Suppl):116S-118S. PubMed ID: 8094045
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice.
    Ruan S; Samuelson DR; Assouline B; Morre M; Shellito JE
    Infect Immun; 2016 Jan; 84(1):108-19. PubMed ID: 26483405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.